Clinical Trials Logo

Clinical Trial Summary

The investigators have developed a proprietary blend of amino acids that they think will help to prevent or reduce the severity of delirium in older people who are hospitalized for certain infections. In this study, up to 45 people will be enrolled. 15 will be asked to drink this blend twice a day for up to 1 week, and 15 will drink a placebo (sugar water) for the same time period. The other 15 subjects will be non-delirious control subjects who do not consume any study products.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05066503
Study type Interventional
Source University of Arkansas
Contact Gohar Azhar, M.D.
Phone 5015265821
Email [email protected]
Status Recruiting
Phase N/A
Start date November 16, 2020
Completion date March 1, 2023